Description
Product background: Beta-Amyloid peptides (A-beta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be a primary contributor to Alzheimer’s Disease (AD).
About the product: Expressed recombinantly in E. coli, Beta-Amyloid (3-42) is purified to our highest standards to ensure batch-to-batch consistency in both purity and quality.
Applications: The Beta-Amyloid (3-42) peptide is supplied in the NH4OH counter-ion ensuring a highly monomeric starting material that may be suited to aggregation studies, seeding experiments, molecular standards and more.
